{"organizations": [], "uuid": "188f8534a1455f61dd6b7a8eb5a3962e77342d06", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-emd-serono-co-pfizer-canada-announ/brief-emd-serono-says-health-canada-approves-bavencio-for-treating-metastatic-merkel-cell-carcinoma-idUSFWN1QC169", "country": "US", "domain_rank": 408, "title": "BRIEF-Emd Serono - Co, Pfizer Canada Announce Health Canada Approval For Bavencio For Treating Metastatic Merkel Cell Carcinoma In Previously Treated Adults", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-23T12:32:00.000+02:00", "replies_count": 0, "uuid": "188f8534a1455f61dd6b7a8eb5a3962e77342d06"}, "author": "", "url": "https://www.reuters.com/article/brief-emd-serono-co-pfizer-canada-announ/brief-emd-serono-says-health-canada-approves-bavencio-for-treating-metastatic-merkel-cell-carcinoma-idUSFWN1QC169", "ord_in_thread": 0, "title": "BRIEF-Emd Serono - Co, Pfizer Canada Announce Health Canada Approval For Bavencio For Treating Metastatic Merkel Cell Carcinoma In Previously Treated Adults", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "pfizer canada announc", "sentiment": "neutral"}, {"name": "serono - co", "sentiment": "neutral"}, {"name": "pfizer", "sentiment": "none"}, {"name": "serono", "sentiment": "none"}, {"name": "merck kgaa", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News February 22, 2018 / 7:17 PM / Updated 25 minutes ago BRIEF-Emd Serono - Co, Pfizer Canada Announce Health Canada Approval For Bavencio For Treating Metastatic Merkel Cell Carcinoma In Previously Treated Adults Reuters Staff 1 Min Read Merck Kgaa: * EMD SERONO - CO, PFIZER CANADA ANNOUNCE HEALTH CANADA APPROVAL FOR BAVENCIO FOR TREATING METASTATIC MERKEL CELL CARCINOMA IN PREVIOUSLY TREATED ADULTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-23T12:32:00.000+02:00", "crawled": "2018-02-23T12:49:16.025+02:00", "highlightTitle": ""}